Elsevier Announces Title Change and New Editor-In-Chief for Cancer Genetics and Cytogenetics Journal
First issue of Cancer Genetics under editorial leadership of Dr. Jaclyn A. Biegel to be published January 2011
Oxford, UK, 6 December 2010 – Elsevier, the world's leading publisher of scientific, technical and medical information, announced today that its highly respected Cancer Genetics and Cytogenetics journal is changing its title to Cancer Genetics and has named Dr. Jaclyn A. Biegel as editor-in-chief.
The changes reflect broader aims and scope for the journal, with a new focus on diagnostic applications as well as the genetic predisposition of cancer, and mark an important move by Elsevier to provide the STM community with a wider variety of original, clinically relevant information for the diagnosis, prognosis and risk evaluation of cancer patients and a greater understanding of how altered gene regulation will ultimately lead to new, targeted therapies for treatment. The first issue of Cancer Genetics will be published in January 2011, with a new cover and interior design.
Journal Editor-in-Chief Dr. Jaclyn A. Biegel, said, “In addition to papers on the cellular, genetic and molecular aspects of cancer, I look forward to publishing a greater number of articles in the areas of genetic predisposition to cancer, personalized medicine, and new diagnostic approaches. We [also] welcome the submission of classical cytogenetic reports.”
“This is an extraordinary time to work in the field of cancer genetics, as we continue to elucidate
the genetic etiology of the many different diseases we call cancer, and enter the era of personalized medicine. In the coming years, we hope to address all of these aspects of cancer research, from gene discovery to risk assessment and treatment, in Cancer Genetics,” she added.
Editor-in-Chief Dr. Jaclyn A. Biegel is the Director of the Cancer Cytogenetics Laboratory at the Children’s Hospital of Philadelphia and a Professor of Pediatrics at the University of Pennsylvania School of Medicine. Her clinical expertise is in the diagnosis of pediatric leukemia and solid tumors, and her research expertise is in the genetics of pediatric brain tumors and rhabdoid tumors.
# # #
About Cancer Genetics
Cancer Genetics (http://www.cancergeneticsjournal.org/), formerly Cancer Genetics and Cytogenetics, is published 12 times a year. It has been published continuously since 1979, a time when cancer cytogenetics was just emerging as a discipline, and investigators in pathology, oncology and genetics were only beginning to assess the genetic basis for hematologic malignancies and solid tumors.
Elsevier is a global information analytics company that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a world-leading provider of information and analytics to professionals and business customers, in a wide range of industries. www.elsevier.com
+44 (0)20 7424 4404